Moogene Medi Co., Ltd.

A322970

KR7322970005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-19 pm EDT			5-day change	1st Jan Change
1,900 ^KRW	+1.12%		-6.40%	-31.28%

2023	Moogene Medi Co., Ltd. announced that it has received KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	CI
2023	Moogene Medi Co., Ltd. announced that it expects to receive KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	CI

Moogene Medi Co., Ltd. announced that it has received KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.

April 14, 2022

On April 15, 2022, Moogene Medi Co., Ltd. closed the transaction.

Latest news about Moogene Medi Co., Ltd.

Moogene Medi Co., Ltd. announced that it has received KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	Dec. 14	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	Dec. 06	CI
Moogene Medi Co., Ltd. announced that it has received KRW 6.999994554 billion in funding from Pion-Tech Co., Ltd.	23-07-17	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 7.999993302 billion in funding from Pion-Tech Co., Ltd. and other investors	23-07-02	CI
Moogene Medi Co., Ltd. announced that it has received KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.	22-04-14	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.	22-04-06	CI

Moogene medi Co Ltd is a Korea-based company mainly engaged in the research and development of biological and chemical agents capable of treating incurable diseases. The Company mainly manufactures and sells medicines such as treatments of colorectal cancer, treatments for hair loss, and treatments for diabetes.

Sector

Biotechnology & Medical Research

Calendar

2024-06-24 - Investor Meeting

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MOOGENE MEDI CO., LTD.	-31.28%	13.62M
MODERNA, INC.	+35.14%	51.07B
IQVIA HOLDINGS INC.	-7.43%	38.78B
LONZA GROUP AG	+35.88%	38.61B
CELLTRION, INC.	-10.62%	27.32B
ICON PUBLIC LIMITED COMPANY	+11.63%	26.35B
ALNYLAM PHARMACEUTICALS, INC.	-17.77%	19.46B
UNITED THERAPEUTICS CORPORATION	+40.52%	13.58B
MEDPACE HOLDINGS, INC.	+30.70%	12.46B
BIO-TECHNE CORPORATION	-3.41%	11.75B

Other Biotechnology & Medical Research

Moogene Medi Co., Ltd.

Equities

A322970

KR7322970005

Biotechnology & Medical Research

Moogene Medi Co., Ltd. announced that it has received KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.

Latest news about Moogene Medi Co., Ltd.

Chart Moogene Medi Co., Ltd.

Company Profile

Sector Other Biotechnology & Medical Research